Investors

To participate in the conference call, please dial one of the following numbers 15 minutes prior to the start of the call: United States: +1-866-575-6539; International: +1-929-477-0402; and Israel: +972-3-376-1315. The access code for the call is: 2166581.

Members of RedHill’s executive team will be joined by the study’s lead investigator and key opinion leader, Professor David Y. Graham, M.D., M.A.C.G., and will discuss TALICIA^®, the ERADICATE Hp2 study, H. pylori infection, the current treatment landscape and potential market. A question and answer session will be held following the presentations.

Participants who wish to ask questions during the event can do so by dialing in to the event. To participate in the conference call, please dial one of the following numbers 5-10 minutes prior to the start of the call: United States: +1-800-458-4121; International: +1-929-477-0324; and Israel: +972-3-376-1315. The access code for the call is: 5774327.